SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-109130
Filing Date
2023-10-13
Accepted
2023-10-13 16:42:44
Documents
12
Period of Report
2023-10-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2328467d1_8k.htm   iXBRL 8-K 26536
  Complete submission text file 0001104659-23-109130.txt   198426

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rsls-20231010.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20231010_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20231010_pre.xml EX-101.PRE 22381
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2328467d1_8k_htm.xml XML 3220
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 231325465
SIC: 3841 Surgical & Medical Instruments & Apparatus